Vericel News

Vericel Analyst Ratings

BenzingaMar 26 09:14 ET

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)

TipRanksMar 26 08:50 ET

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)

TipRanksMar 24 21:40 ET

Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV)

TipRanksMar 1 07:40 ET

Vericel Analyst Ratings

BenzingaMar 1 07:32 ET

Buy Rating Affirmed for Vericel on Strong Financials and Growth Prospects

TipRanksMar 1 06:26 ET

BTIG Keeps Their Buy Rating on Vericel (VCEL)

TipRanksFeb 22 05:25 ET

BTIG Remains a Buy on Vericel (VCEL)

TipRanksFeb 20 06:15 ET

Vericel Upgraded at Truist on Growth Acceleration Potential

Seeking AlphaJan 25 14:44 ET

Vericel Analyst Ratings

BenzingaJan 25 06:28 ET

HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $46

BenzingaJan 16 07:20 ET

Vericel Analyst Ratings

BenzingaJan 16 07:18 ET

Leerink Partners Remains a Buy on Vericel (VCEL)

TipRanksJan 11 01:41 ET

BTIG Reaffirms Their Hold Rating on Vericel (VCEL)

TipRanksJan 2 09:54 ET

BTIG Sticks to Its Buy Rating for Vericel (VCEL)

TipRanksDec 31, 2023 05:28 ET

Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Irhythm Technologies (IRTC) and Meiragtx Holdings (MGTX)

TipRanksDec 25, 2023 21:30 ET

Vericel's Growth Potential and Distinct Product Profiles: The Basis for a Buy Rating

TipRanksNov 22, 2023 10:05 ET

Vericel Stock's Promising Outlook: Buy Rating, Increased Price Target, and High-Growth MedTech Potential

TipRanksNov 10, 2023 06:39 ET

Vericel Analyst Ratings

BenzingaNov 9, 2023 16:49 ET

Hold Rating on Vericel: A Measured Approach on Future Growth Amid Slower NexoBrid Ramp and Valuation Concerns

TipRanksNov 9, 2023 12:42 ET